Gene: EEF1B2
Official Full Name: eukaryotic translation elongation factor 1 beta 2provided by VGNC
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO01317 | EEF1B2 Knockout cell line (PK-15) | Pig | EEF1B2 | 1:2-1:4 | Negative | Online Inquiry |
EEF1B2 Gene Knockout Cell Lines are specifically developed cellular models designed to study the physiological and biological functions of the EEF1B2 gene, which encodes a crucial component of the eukaryotic translation elongation factor complex. This product offers a powerful tool for researchers aiming to dissect the role of EEF1B2 in various cellular processes, including protein synthesis, stress response, and translational fidelity. Knocking out the EEF1B2 gene allows for the examination of resulting phenotypic changes, illuminating the gene’s contribution to cellular homeostasis and pathophysiological conditions.
The key mechanism of action for these knockout cell lines relies on CRISPR/Cas9 technology, which introduces a targeted double-strand break in the EEF1B2 gene. Subsequent cellular repair processes are harnessed to create frameshift mutations, effectively silencing the gene. This results in a cellular environment where the contribution of EEF1B2 can be directly measured, providing insights into its biological significance across various experimental conditions.
The scientific relevance of EEF1B2 knockout cell lines spans diverse fields, such as cancer biology, neurological disorders, and metabolic diseases. In research settings, these models enable the study of gene function in the context of cellular pathways, while in clinical applications, they may facilitate the identification of potential therapeutic targets and the development of gene therapies.
Distinctively, EEF1B2 gene knockout cell lines offer several advantages over similar products, including enhanced specificity and reproducibility in gene editing, comprehensive validation protocols, and user-friendly handling procedures. Additionally, they provide researchers with a high degree of genetic stability and robustness, qualities that are essential for obtaining reliable and interpretable results.
For researchers and clinicians committed to unraveling the complexities of cellular function and disease mechanisms, EEF1B2 Gene Knockout Cell Lines represent an invaluable asset that paves the way for innovative discoveries. Our company, with its extensive expertise in genetic engineering and cell line development, offers a commitment to delivering high-quality biological products that empower the scientific community to advance their research agendas efficiently.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.